GlassScriptPhysician profile
Daniel J Pipoly
NPI 1598746125
$1,386.18
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $290 · 2020: $163 · 2021: $250 · 2022: $683.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $466.60 | 2019-2022 | |
| Harmony Biosciences LLC | $142.44 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.26 | 2020-2022 | |
| Genzyme Corporation | $95.88 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $87.59 | 2019-2022 | |
| Genentech USA, INC. | $70.72 | 2019-2022 | |
| Arbor Pharmaceuticals, INC. | $59.74 | 2019-2021 | |
| Insmed, INC. | $45.44 | 2019-2022 | |
| Glaxosmithkline, LLC. | $37.93 | 2019-2021 | |
| Electromed, INC. | $32.26 | 2019-2022 | |
| Advanced Respiratory, INC | $30.84 | 2019-2020 | |
| Amgen INC. | $29.94 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $29.68 | 2021 | |
| Mylan Specialty L.P. | $27.93 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $24.80 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $23.04 | 2022 | |
| Ani Pharmaceuticals, INC. | $18.51 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.99 | 2020 | |
| Novartis Pharmaceuticals Corporation | $16.52 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $13.09 | 2019 | |
| Baxter Healthcare | $11.89 | 2022 | |
| Z-Medica, LLC | $7.09 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Pipoly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.